home ver. 2.3. site index contact us

Message from the CEO
How We Work
Business Integrity
History of Schering-Plough
Management Team
Schering-Plough Worldwide
Speeches & Presentations
The Schering-Plough Foundation
Diversity & Inclusion
Supplier Registration
Diversity Colleague Demographics

Management Team

Executive Management Team (EMT) and Advisors Operations Management Team (OMT)



Fred Hassan*
Chairman of the Board and Chief Executive Officer

Stanley F. Barshay
Chairman, Consumer Health Care

Jeff Berkowitz
Group Vice President, Global Market Access and U.S. Managed Markets

Robert J. Bertolini*
Executive Vice President and Chief Financial Officer

Richard S. Bowles III*
Senior Vice President, Global Quality Operations

John M. Carroll
Vice President, Global Internal Audits

C. Ron Cheeley*
Senior Vice President, Global Human Resources

Carrie S. Cox*
Executive Vice President and President, Global Pharmaceuticals

Lisa DeBerardine
Vice President, Strategic Planning and Financial Forecasting

Michael DuBois
Senior Vice President, Global Licensing & Strategic Alliances

Margriet Gabriel-Regis
Senior Vice President, Specialty Care Customer Group

Ellen Geisel
Senior Vice President, Primary Care Customer Group

Francesco Granata
Group Vice President and President, EUCAN Region I

Maria Teresa Hilado
Vice President & Treasurer

Alex Kelly
Group Vice President, Global Communications and Investor Relations

Steven Koehler
Vice President and Controller

Thomas P. Koestler*
Executive Vice President and President, Schering-Plough Research Institute

Raul E. Kohan*
Senior Vice President, Corporate Excellence and Deputy Head, Global Animal Health

Ismail Kola
Senior Vice President, Discovery Research, Schering-Plough Research Institute, and Chief Scientific Officer

Peter Kuiper
Group Vice President, Operations - The Netherlands

James MacDonald
Executive Vice President, Preclinical Development

Ian McInnes*
Senior Vice President and President, Global Supply Chain

Sean McNicholas
Senior Vice President, Cardiovascular Products and U.S. Sales, Global Pharmaceutical Business

C. David Nicholson
Senior Vice President, Global Project Management

David A. Piacquad
Senior Vice President, Business Development

Lori Queisser*
Senior Vice President, Global Compliance and Business Practices

Thomas Sabatino, Jr.*
Executive Vice President & General Counsel

Karl D. Salnoske
Vice President and Chief Information Officer

Brent Saunders*
Senior Vice President and President, Consumer Health Care

Robert J. Spiegel, M.D.
Chief Medical Officer and Senior Vice President, Schering-Plough Research Institute

Ruurd Stolp*
Senior Vice President and President, Global Animal Health

Bruno Strigini
Group Vice President and President, EUCAN Region II

Gregory J. Szpunar
Senior Vice President, Pharmaceutical Sciences, Schering-Plough Research Institute.

Mark Torii
President, SPKK, Japan

Rodney Unsworth
Group Vice President and President, Asia-Pacific Region

Pierre Verstraete
Group Vice President and President, Latin America

Susan Ellen Wolf
Corporate Secretary, Vice President - Corporate Governance and Associate General Counsel


*Executive Management Team member

Spotlight On

Combination Brochure

Brochure on the Combination

Basic Facts and Figures
•  World Headquarters:
2000 Galloping Hill Road, Kenilworth, N.J. 07033-0530
•  Chairman and CEO:
Fred Hassan
Number of employees:
55,000
Net sales (2007):
$12.7 billion
Business operations in more than:
140 countries
Largest-selling products:
VYTORIN*, ZETIA*, REMICADE, NASONEX.
R&D investment (2007):
$2.9 billion
Areas of research:
cardiovascular disease, central nervous system disorders, immunology and infectious disease, oncology, respiratory diseases and women's health

*VYTORIN and ZETIA are managed through a joint venture with Merck & Co., Inc. Schering-Plough accounts for the joint venture under the Equity method. Total cholesterol joint venture sales were $5.2 billion in 2007.
 
                                      © 2003-2008 Schering-Plough Corporation.
                 Please see our legal notice, privacy policy and forward-looking statement.
Schering-Plough Schering-Plough skip to content Schering-Plough